Issues and Practices in Multiple Sclerosis

Jack S. Burks; Barry G. Arnason; Patricia K. Coyle; Corey C. Ford; Avertano Noronha; Kottil W. Rammohan

doi:10.1177/154596830201600401

Issues and Practices in Multiple Sclerosis

Jack S. Burks, Barry G. Arnason, Patricia K. Coyle, Corey C. Ford, Avertano Noronha, Kottil W. Rammohan

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

The objective of this roundtable discussion of experts in the field of multiple sclerosis (MS) was to summarize the current understanding of MS and its therapeutic options. The experts discussed subjects ranging from the etiology of MS to the current standards for patient care. Specific topics included the subtypes of MS, with a focus on the benign subtype, brain atrophy, the role of magnetic resonance imaging or "neuroimaging studies," disease-modifying therapies, biological markers as indicators of drug efficacy, and combination therapies. In addition, the experts speculated as to what will be available in the near future for the improved diagnosis and management of MS. This review summarizes the main points of this discussion and is intended to serve as a reference for neurologists involved in the care of patients with MS.

Original language	English (US)
Pages (from-to)	307-320
Number of pages	14
Journal	Neurorehabilitation and Neural Repair
Volume	16
Issue number	4
DOIs	https://doi.org/10.1177/154596830201600401
State	Published - Dec 2002
Externally published	Yes

Keywords

Adverse effects
Brain atrophy
Glatiramer acetate
Immunotherapy
Interferon-β
Magnetic resonance imaging
Mitoxantrone
Multiple sclerosis

ASJC Scopus subject areas

Rehabilitation
Clinical Neurology
Neuroscience(all)
Health Professions(all)

Access to Document

10.1177/154596830201600401

Cite this

@article{91d32cda49574a45b83ffc7fd69ea034,

title = "Issues and Practices in Multiple Sclerosis",

abstract = "The objective of this roundtable discussion of experts in the field of multiple sclerosis (MS) was to summarize the current understanding of MS and its therapeutic options. The experts discussed subjects ranging from the etiology of MS to the current standards for patient care. Specific topics included the subtypes of MS, with a focus on the benign subtype, brain atrophy, the role of magnetic resonance imaging or {"}neuroimaging studies,{"} disease-modifying therapies, biological markers as indicators of drug efficacy, and combination therapies. In addition, the experts speculated as to what will be available in the near future for the improved diagnosis and management of MS. This review summarizes the main points of this discussion and is intended to serve as a reference for neurologists involved in the care of patients with MS.",

keywords = "Adverse effects, Brain atrophy, Glatiramer acetate, Immunotherapy, Interferon-β, Magnetic resonance imaging, Mitoxantrone, Multiple sclerosis",

author = "Burks, {Jack S.} and Arnason, {Barry G.} and Coyle, {Patricia K.} and Ford, {Corey C.} and Avertano Noronha and Rammohan, {Kottil W.}",

year = "2002",

month = dec,

doi = "10.1177/154596830201600401",

language = "English (US)",

volume = "16",

pages = "307--320",

journal = "Journal of Neurologic Rehabilitation",

issn = "1545-9683",

publisher = "Sage Science Press",

number = "4",

}

TY - JOUR

T1 - Issues and Practices in Multiple Sclerosis

AU - Burks, Jack S.

AU - Arnason, Barry G.

AU - Coyle, Patricia K.

AU - Ford, Corey C.

AU - Noronha, Avertano

AU - Rammohan, Kottil W.

PY - 2002/12

Y1 - 2002/12

N2 - The objective of this roundtable discussion of experts in the field of multiple sclerosis (MS) was to summarize the current understanding of MS and its therapeutic options. The experts discussed subjects ranging from the etiology of MS to the current standards for patient care. Specific topics included the subtypes of MS, with a focus on the benign subtype, brain atrophy, the role of magnetic resonance imaging or "neuroimaging studies," disease-modifying therapies, biological markers as indicators of drug efficacy, and combination therapies. In addition, the experts speculated as to what will be available in the near future for the improved diagnosis and management of MS. This review summarizes the main points of this discussion and is intended to serve as a reference for neurologists involved in the care of patients with MS.

AB - The objective of this roundtable discussion of experts in the field of multiple sclerosis (MS) was to summarize the current understanding of MS and its therapeutic options. The experts discussed subjects ranging from the etiology of MS to the current standards for patient care. Specific topics included the subtypes of MS, with a focus on the benign subtype, brain atrophy, the role of magnetic resonance imaging or "neuroimaging studies," disease-modifying therapies, biological markers as indicators of drug efficacy, and combination therapies. In addition, the experts speculated as to what will be available in the near future for the improved diagnosis and management of MS. This review summarizes the main points of this discussion and is intended to serve as a reference for neurologists involved in the care of patients with MS.

KW - Adverse effects

KW - Brain atrophy

KW - Glatiramer acetate

KW - Immunotherapy

KW - Interferon-β

KW - Magnetic resonance imaging

KW - Mitoxantrone

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0036891530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036891530&partnerID=8YFLogxK

U2 - 10.1177/154596830201600401

DO - 10.1177/154596830201600401

M3 - Article

C2 - 12462762

AN - SCOPUS:0036891530

VL - 16

SP - 307

EP - 320

JO - Journal of Neurologic Rehabilitation

JF - Journal of Neurologic Rehabilitation

SN - 1545-9683

IS - 4

ER -

Issues and Practices in Multiple Sclerosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this